ArticleMolecules (Basel, Switzerland)2026
LogPpred: An AI-Based Predictive Model for Accurate Estimation of Molecular LogP.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lipophilicity, commonly described by the n-octanol/water partition coefficient (LogP), is a key physicochemical property influencing the pharmacokinetic behavior of small molecules. Reliable LogP estimation during the early stages of drug discovery is essential to support molecular design and prioritize compounds with favorable ADMET properties. In this work, we report the development of LogPpred, an AI-based predictor of molecular lipophilicity. Starting from a curated dataset of 13,536 molecules with experimentally determined LogP values, multiple machine learning algorithms and molecular representations were systematically evaluated. The best-performing model, based on Gaussian Process Regression and RDKit molecular descriptors, achieved a mean absolute error (MAE) of 0.34 on the independent internal test set. External validation on a fully independent OECD-derived dataset yielded an MAE of 0.84, demonstrating good generalization capability across diverse chemical space. Furthermore, experimental LogP determination of an additional set of independently selected compounds confirmed the predictive reliability of the model, yielding an MAE of 0.66. Comparative analyses showed that LogPpred outperformed several widely used LogP prediction tools. Applicability domain analysis further supported the reliability of the model, with MAE values improving to 0.28 and 0.62 for in-domain compounds in the internal and external validation sets, respectively. Overall, LogPpred represents a robust, accurate, and transparent tool for the early assessment of molecular lipophilicity in medicinal chemistry and drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.